LQDA Short Volume
Liquidia Corporation (LQDA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $6.95B, listed on NASDAQ, employing roughly 170 people, carrying a beta of 0.59 to the broader market. Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. Led by Roger A. Jeffs, public since 2018-07-26.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-30
- Short Volume
- 358.5K
- Total Volume
- 636.9K
- Short %
- 56.29%
- 30-Day Avg Short %
- 56.26%
Showing 30 days of FINRA short volume data for Liquidia Corporation.
Learn how short volume is reported and how to read the data →
Frequently asked LQDA short volume questions
- What is the daily LQDA short volume?
- As of Jun 30, 2026, Liquidia Corporation (LQDA) short volume is 358.5K shares against 636.9K total reported volume, or 56.29% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is LQDA short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does LQDA short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.